X-LINKED RECESSIVE FORM OF NEPHROGENIC
DIABETES INSIPIDUS IN A 7-YEAR-OLD BOY Janchevska A1,*, Tasic V1, Gucev Z1, Krstevska-Konstantinova M1, Cheong HI2,3,4 *Corresponding Author: Dr. Aleksandra Janchevska, Department of endocrinology and genetics, University
Children’s Hospital Skopje, Medical Faculty, 1000 Skopje, Republic of Macedonia. Tel: +389-2-3147-474. Fax:
+389-2-3129-027. E-mail: dr.sasha1969@yahoo.com page: 81
|
INTRODUCTION
an acquired illness in the majority of patients, but
very rarely has a hereditary origin. There are two
wellknown hereditary forms of NDI, type 1 and type
2. The majority of patients (about 90.0%) have type
1, an X-linked recessive form of NDI caused by mutations
in the AVPR2 gene encoding the vasopressin
V2 receptor. The patients are predominantly males,
but women are healthy or asymptomatic carriers. The
remaining 10.0% of patients carry type 2, autosomal
NDI. This type is caused by the aquaporin-2 water
channel (AQP2) gene mutations [1].
Nephrogenic diabetes insipidus is caused by the
inability of renal collecting duct cells to respond to
antidiuretic action of arginine vasopressin (AVP).
This antidiuretic hormone (ADH) action in kidneys
is regulated by three subtypes of G protein coupled
AVP receptors. The V1A and V1B type receptors act
through Gq proteins and the phospholipase C activation
system, but V2 receptor acts through adenyl cyclase
and Gs proteins activation system [2- 4]. Renal
collecting duct cells cannot reabsorb the water and the
kidneys produce a large amount of low concentrated urine as a result of mutations of the AVPR2 gene in
type 1 NDI patients.
|
|
|
|
|
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|